BRAF and colorectal cancer: Metastatic Lynch and Lynch-like colorectal cancers (in which BRAF mutations are largely absent) have increased DFS and OS compared with sporadic MSI colorectal cancer, although the typically younger age of patients with Lynch syndrome is a confounding factor.16